In this interview, Thomas Van Dyke, DDS, PhD talks about the current role of nutraceuticals in managing inflammation associated with periodontal disease. He elaborates on the use of Omega-3s derivatives such as specialized pro-resolving mediators (SPMs) as an adjunctive therapy in periodontal disease. Additionally, Dr. Van Dyke explains the connection between periodontal infections and increased risk of cardiovascular incidents, emphasizing the advantages of controlling inflammation. He concludes by discussing his ongoing research on using lipoxins and resolvins for the treatment and prevention of periodontal disease.
Thomas Van Dyke, DDS, PhD, is the VP of Clinical and Translational Research at the Forsyth Institute. He is a Professor in Oral Medicine, Infection, and Immunity, at Harvard University.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
